Evidence map›Paper›PMID 21705483›Full record

ArticleCarcinogenesis2011

Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent.

Emanuela Taioli, Rafael E Flores-Obando, Ilir Agalliu, Pascal Blanchet, Clareann H Bunker, Robert E Ferrell, Maria Jackson, La Creis R Kidd, Suzanne Kolb, Nicol A Lavender and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. An updated meta-analysis of the association between GSTM1 polymorphism and colorectal cancer in Asians.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  4. Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Interaction betweenResearch in autism spectrum disorders · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 17 institutions in 5 countries.

Emanuela TaioliInstitute of Translational Epidemiology, Mount Sinai School of Medicine, New York, NY, USA. taiolema@gmail.com
Rafael E Flores-Obando
Ilir Agalliu
Pascal Blanchet
Clareann H Bunker
Robert E Ferrell
Maria Jackson
La Creis R Kidd
Suzanne Kolb
Nicol A Lavender
Norma McFarlane-Anderson
Seian S Morrison
Luc Multigner
Elaine A Ostrande
Jong Y Park
Alan L Patrick
Timothy R Rebbeck
Marc Romana
Janet L Stanford
Flora Ukoli
Tiva T Vancleave
Charnita M Zeigler-Johnson
Batsirai Mutetwa
Camille Ragin
Fred Hutch Cancer Center · USJames Graham Brown Foundation · USMoffitt Cancer Center · USSUNY Downstate Health Sciences University · USUniversity of the West Indies System · JMAlbert Einstein College of Medicine · USCancer Genetics (United States) · USFox Chase Cancer Center · USIcahn School of Medicine at Mount Sinai · USInserm · FRInstitut de Recherche en Santé, Environnement et Travail · FRInstitut Pasteur de la Guadeloupe · GPMeharry Medical College · USUniversity of Louisville · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USUniversity of Trinidad and Tobago · TT

Funding

Segregation and Racial Disparities in Prostate CancerP50CA105641 · NCI · UNIVERSITY OF PENNSYLVANIA · PI REBBECK, TIMOTHY R · 2003 to 2009
$9.6M
NSAIDS and Other Medications in Prostate Cancer EtiologyR01CA092579 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STANFORD, JANET L · 2001 to 2005
$3.2M
PHARMACOGENETICS OF DRUG &CARCINOGEN METABOLISMR01CA034627 · NCI · UNIVERSITY OF NORTH DAKOTA · PI HEIN, DAVID W · 1985 to 2009
$3.1M
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCERR01CA085074 · NCI · UNIVERSITY OF PENNSYLVANIA · PI REBBECK, TIMOTHY R · 1999 to 2010
$2.9M
Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancerR01CA128813 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI PARK, JONG Y. · 2008 to 2012
$2.0M
A Pharmacogenetic approach to prostate cancer susceptibilityR03CA128028 · NCI · UNIVERSITY OF LOUISVILLE · PI KIDD, LA CREIS RENEE · 2007 to 2008
$148k
PROSTATE CANCER IN RELATION TO VASECTOMYR01CA056678 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STANFORD, JANET L · 1993 to 1997
–
NCI NIH HHS P50-CA105641NCI NIH HHS R01 CA034627NCI NIH HHS R01-CA056678NCI NIH HHS R01-CA085074NCI NIH HHS R01-CA092579NCI NIH HHS R01 CA128813NCI NIH HHS R03 CA128028
6 · The paper itself

Abstract

Prostate cancer disparities have been reported in men of African descent who show the highest incidence, mortality, compared with other ethnic groups. Few studies have explored the genetic and environmental factors for prostate cancer in men of African ancestry. The glutathione-S-transferases family conjugates carcinogens before their excretion and is expressed in prostate tissue. This study addressed the role of GSTM1 and GSTT1 deletions on prostate cancer risk in populations of African descent. This multi-institutional case-control study gathered data from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database, the African-Caribbean Cancer Consortium (AC3) and Men of African Descent and Carcinoma of the Prostate Consortium (MADCaP). The analysis included 10 studies (1715 cases and 2363 controls), five in African-Americans, three in African-Caribbean and two in African men. Both the GSTM1 and the GSTT1 deletions showed significant inverse associations with prostate cancer [odds ratio (OR): 0.90, 95% confidence interval (CI) 0.83-0.97 and OR 0.88, 95% CI: 0.82-0.96, respectively]. The association was restricted to Caribbean and African populations. A significant positive association was observed between GSTM1 deletion and prostate cancer in smokers in African-American studies (OR: 1.28, 95% CI: 1.01-1.56), whereas a reduced risk was observed in never-smokers (OR: 0.66, 95% CI: 0.46-0.95). The risk of prostate cancer increased across quartiles of pack-years among subjects carrying the deletion of GSTM1 but not among subjects carrying a functional GSTM1. Gene-environment interaction between smoking and GSTM1 may be involved in the etiology of prostate cancer in populations of African descent.

Indexed as

Genetic Predisposition to DiseaseAgedBlack or African AmericanGene DeletionGlutathione TransferaseHumansMaleMiddle AgedProstatic NeoplasmsSmokingglutathione S-transferase T1Glutathione Transferase

Identifiers

PMID21705483
PMCPMC3165127
OpenAlexW2153981527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.